Cutler Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-209
Closed -$12K 5616
2021
Q4
$12K Sell
209
-2,000
-91% -$113K ﹤0.01% 3533
2021
Q3
$130K Buy
2,209
+2,059
+1,373% +$162K 0.01% 1704
2021
Q2
$13K Hold
150
﹤0.01% 3671
2021
Q1
$12K Sell
150
-1,230
-89% -$118K ﹤0.01% 3640
2020
Q4
$125K Buy
+1,380
New +$85.7K 0.01% 1388
2020
Q3
Sell
-1,300
Closed -$45.4K 4946
2020
Q2
$44K Buy
+1,300
New +$38.7K ﹤0.01% 1833
2020
Q1
Sell
-700
Closed -$17.7K 4296
2019
Q4
$13K Buy
+700
New +$11.1K ﹤0.01% 2482
2019
Q3
Hold
0
4380
2019
Q2
Hold
0
4541
2019
Q1
Hold
0
4359
2018
Q4
Hold
0
4230
2018
Q3
Sell
-1,000
Closed -$11.8K 4389
2018
Q2
$11K Buy
+1,000
New +$11K ﹤0.01% 2596

Other funds holding FATE